These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Screening, Docking, and Molecular Dynamics Study of Natural Compounds as an Anti-HER2 for the Management of Breast Cancer. Sohrab SS; Kamal MA Life (Basel); 2022 Oct; 12(11):. PubMed ID: 36362883 [TBL] [Abstract][Full Text] [Related]
9. Virtual screening, pharmacokinetics, molecular dynamics and binding free energy analysis for small natural molecules against cyclin-dependent kinase 5 for Alzheimer's disease. Shukla R; Singh TR J Biomol Struct Dyn; 2020 Jan; 38(1):248-262. PubMed ID: 30688165 [TBL] [Abstract][Full Text] [Related]
10. Molecular docking and molecular dynamics simulation approach to screen natural compounds for inhibition of Joshi T; Joshi T; Sharma P; Chandra S; Pande V J Biomol Struct Dyn; 2021 Feb; 39(3):823-840. PubMed ID: 31965918 [No Abstract] [Full Text] [Related]
12. Identification of Natural Inhibitors Against SARS-CoV-2 Drugable Targets Using Molecular Docking, Molecular Dynamics Simulation, and MM-PBSA Approach. Kushwaha PP; Singh AK; Bansal T; Yadav A; Prajapati KS; Shuaib M; Kumar S Front Cell Infect Microbiol; 2021; 11():730288. PubMed ID: 34458164 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of phytoconstituents of Choudhary P; Singh T; Amod A; Singh S J Biomol Struct Dyn; 2023 Jun; 41(9):4106-4123. PubMed ID: 35467486 [TBL] [Abstract][Full Text] [Related]
14. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817 [TBL] [Abstract][Full Text] [Related]
15. Exploration of selected monoterpenes as potential TRPC channel family modulator in lung cancer, an Singh A; Mishra A; Meena A; Mishra N; Luqman S J Biomol Struct Dyn; 2024 Sep; 42(15):7917-7933. PubMed ID: 37526232 [TBL] [Abstract][Full Text] [Related]
17. Exploring the Anticancer Potential of Furanpydone A: A Computational Study on its Inhibition of MTHFD2 Across Diverse Cancer Cell Lines. Alhawarri MB Cell Biochem Biophys; 2024 Aug; ():. PubMed ID: 39110299 [TBL] [Abstract][Full Text] [Related]
18. Assessment of iridoids and their similar structures as antineoplastic drugs by Neupane P; Adhikari Subin J; Adhikari R J Biomol Struct Dyn; 2024 Feb; ():1-16. PubMed ID: 38345021 [TBL] [Abstract][Full Text] [Related]